Author:
Salem Hesham,Mazen Dina Z.,Heshmat Dina,Mahmoud Mohamed M.,Ali Ebtisam,Abdelaziz Amany
Abstract
AbstractAn inexpensive, simple, sensitive and validated approach is developed for estimation of fingolimod through production of colored charge transfer complexes of fingolimod with different electron acceptor reagents, including a reaction of fingolimod as n-donor with 7,7,8,8-tetracyanoquinodimethane, tetrachloro 1,4-benzoquinone and tetracyanoethylene and as n-acceptors, yielding colored and stable anions which were measured spectrophotometrically. The range that obeyed Beer’s law is 50–300 µg mL−1 for fingolimod with all the studied reagents. The various parameters that affect the reaction were studied and optimized. The results were statistically compared with a reported method showing equal precision and accuracy. The researched approaches were utilized to determine the cited drug in its pharmaceutical form and spiked human plasma with accepted accuracy and precision.
Publisher
Springer Science and Business Media LLC
Subject
Materials Chemistry,Industrial and Manufacturing Engineering,General Chemical Engineering,Biochemistry,General Chemistry
Reference26 articles.
1. Basavaiah K, Zenita O (2011) Spectrophotometric determination of famotidine using sulphonphthalein dyes. Quim Nova 34:735–742
2. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Burns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453–21457. https://doi.org/10.1074/jbc.C200176200
3. Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9:883–897
4. Chhabda PJ, Balaji M, Srinivasarao V (2013) Development and validation of a stability indicating RP-HPLC method for quantification of fingolimod in bulk and pharmaceutical dosage form. Pharmanest 4:1206–1218
5. Chiba K (2005) FTY720, a new class of immonomodulator, inhibits lymphocyte egres from secondry lymphoid issues and thymus by agonistic activity at sphingosine 1- phosphate receptors. Pharm Ther 108:308–319
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献